All Infectious Disease articles – Page 29
-
NewsResearchers develop potential vaccine against antibiotic-resistant enterococci
Researchers have discovered how to create an enterococcal vaccine that is relatively easy to produce and takes advantage of membrane vesicles.
-
NewsNovel compounds promise success in the fight against tuberculosis and depression
Scientists have shown that a specific polyprenylated polycyclic acylphloroglucinol, PPAP53, is able to activate human macrophages to fight resistant tuberculosis bacteria without being toxic to the macrophages themselves.
-
NewsStudy reveals how bacteria use snot to swarm and spread infection
New research shows how thicker mucus supercharges bacteria’s ability to self-organize into swarms to spread infection.
-
NewsNew institute to bolster global preparedness for future pandemics
The University of Hong Kong (HKU), the University of Cambridge (UCAM), and the International Vaccine Institute (IVI) have established the international headquarters of The Hong Kong Jockey Club Global Health Institute at HKU.
-
NewsHuman case of flu seen in pigs found in UK for first time
The UK Health Security Agency (UKHSA) has detected a single confirmed human case of influenza A(H1N2)v.
-
NewsWHO makes request to China for information on pneumonia cluster reports in children
WHO has made an official request to China for detailed information on an increase in respiratory illnesses and reported clusters of pneumonia in children.
-
NewsVaccine created to prevent dangerous tropical disease receives FDA approval
The US Food and Drug Administration (FDA) has approved the world’s first vaccine against the chikungunya virus – Ixchiq.
-
NewsResearchers shed light on how one deadly pathogen makes its chemicals
Scientists have deciphered a previously unidentified cluster of genes responsible for producing sartorypyrones, a chemical made by the fungal pathogen Aspergillus fumigatus, whose family causes Aspergillosis in humans.
-
NewsSignificant post-COVID resurgence in invasive meningococcal disease
Scientists have traced the evolution of invasive meningococcal disease cases in France between 2015 and 2022, revealing an unprecedented resurgence in the disease after the easing of control measures imposed during the COVID-19 epidemic.
-
NewsNovel C. diff structures are required for infection and offer new therapeutic targets
Iron storage ‘spheres’ inside the bacterium C. diff — the leading cause of hospital-acquired infections — could offer new targets for antibacterial drugs to combat the pathogen.
-
NewsIron linked to blindness in ocular toxoplasmosis - offering hope for treatment
Researchers have identified the role of iron in ocular toxoplasmosis (OT), a form of toxoplasmosis that causes blindness, and found that treatment of mice with a compound that decreases iron was successful in reducing their symptoms.
-
NewsSaudi Public Health Authority and BGI Genomics sign MoU to advance public health
BGI Genomics has signed a Memorandum of Understanding (MoU) with the Saudi Public Health Authority (PHA) to inject new impetus into the cause of public health in Saudi Arabia.
-
NewsGut bacteria protects against diarrhoeal disease
A new study shows that large animals – including primates - with fewer different kinds of bacteria in their gut are the more severely affected by Cryptosporidiosis. Introducing more diverse gut bacteria can improve outcomes.
-
NewsNew typhoid conjugate vaccine Bio-TCV® approved in Indonesia
Bio Farma’s Bio-TCV® typhoid conjugate vaccine (TCV) has been licensed in Indonesia following marketing approval from Badan Pengawas Obat dan Makanan (BPOM), the national regulatory authority.
-
FeaturesVirgin soil effect: how did European diseases impact native populations in The Americas
The transfer of disease across the ocean is believed to be a major contributor to allowing Spanish conquistadors to take over the Americas. How big of a contributor was infectious disease in the European colonisation?
-
NewsLive shingles vaccine still protecting 10 years on - despite waning effectiveness
The effectiveness of live zoster (shingles) vaccine is highest in the first year after vaccination and then wanes substantially, but it continues to provide some protection against shingles ten years after vaccination.
-
NewsClimate crisis could trigger outbreak of new and lethal infectious diseases
Researchers have identified Candida orthopsilosis, a hybrid microorganism that originated from two other parental fungi in a marine environment, as a potential pathogen that could pose a future threat to human health.
-
NewsVisualizing fungal infections deep in living tissue reveals proline metabolism link to virulence
The first successful application of 2-photon intravital microscopy (IVM) to image the dynamics of fungal infections in the kidney of a living host reveals that Candida albicans requires the ability to metabolize proline to mount virulent infections.
-
NewsEPA testing shows the power of D-I-Y air filters to trap viruses
The results are in: US Environmental Protection Agency research testing of do-it-yourself ‘Corsi-Rosenthal Box’ Indoor Air Filters shows they are 99% effective in removing airborne virus.
-
NewsBoston Children’s Hospital receives a contract of up to $9 million to improve flu vaccines
The Precision Vaccines Program (PVP) at Boston Children’s Hospital has been awarded a contract from NIAID to develop a small molecule adjuvant to enhance the effectiveness of flu vaccines.